Specifically, BMS is taking issue with a decision to deny its rebate plan for big-selling blood thinner Eliquis (apixaban) under the 340B federal drug discount programme – which requires ...

Sanofi is speeding up shipping its respiratory syncytial virus (RSV) preventative antibody Beyfortus to get ahead of what it believes will be strong demand in the 2025–26 season.